David Mitchell

Diagnosed w/multiple myeloma 2010. Completely dependent on innovation & new drugs for survival. Fighting for affordable prices. Founder: @P4AD_ & @P4ADNOW

[David Mitchell @DavidP4AD]

We share our strength when we share our stories. Here's mine. Together we can restore balance to ensure we get the innovative new drugs we need at prices we can afford.

[Chicano Marine 🇲🇽🇺🇸💙 @elchicanomarine]

They’ve lost Joe Rogan…

[David Mitchell @DavidP4AD]

Dominican Republic Travel Advisoryhttps://travel.state.gov/content/travel/en/traveladvisories/traveladvisories/dominican-republic-travel-advisory.html

[Tahir Amin @realtahiramin]

Industry defenders will argue, “but Revlimid has competition.” Here’s @DavidP4AD explaining why that’s not actually true.

[David Mitchell @DavidP4AD]

The Partnership To Fight Chronic Disease-@pfcd-is a Big @PhRMA funded front that doesn't even have support from all the groups it lists on its website. In lobbying reports, PhRMA says the group is a subsidiary. Its Chair-Kenneth Thorpe-was paid $2M 2015-18
https://t.co/IQA2HIAFJC

[David Mitchell @DavidP4AD]

Millions of dollars of secret money from drug companies fund the efforts to undermine Medicare negotiation. The so-callled "pill penalty is a scam/joke. If pharma wants equal time to negotiation for all drugs, let's set it at 9 years. https://t.co/dYhBdyzAjl

[David Mitchell @DavidP4AD]

Important note: The Trump @HHSGov appears to be taking good initial steps to lower Rx prices-implementing the 2022 drug law & especially moving ahead on Medicare negotiation. We applaud them. If this continues as their posture, they have our strong support
https://t.co/IsUkIhjZ67

[Patients For Affordable Drugs NOW @P4ADNOW]

❌ The ORPHAN Cures Act protects Big Pharma profits at the expense of patients and taxpayers. Congress should reject this loophole and pharma giveaway in order to keep Medicare drug price negotiations strong and put patients before drug company greed.

[David Mitchell @DavidP4AD]

Buyer Beware: The American Action Forum is a subsidiary of the American Action Network which has received-are you sitting down-more than $27 million from pharma since 2010. When you see anything from @AAF or @AAN , remember it's all drug company propaganda bought and paid for.

[David Mitchell @DavidP4AD]

As @POTUS meets for at least the 3rd time w/drug company execs, we continue to be disappointed that his administration has not met w/ patients--despite our repeated efforts to engage and offers of support to lower drug prices and help Make America Healthy Again. Below from @Axios

[David Mitchell @DavidP4AD]

There are many reasons for early & speedy approval of new cancer drugs in the U.S. One key reason is that the @US_FDA does a great job. We need to protect & support FDA for patients like me with incurable cancer who need new treatments, and millions of others. h/t @CancerResrch

[David Mitchell @DavidP4AD]

Drug companies continue to tell the courts and Congress that the new drug law that lowers prices is crippling them & harming R&D. Yet, so many of them tell investors they are killing it. Novartis reports best earnings in years.
https://t.co/RYmXth9GWk

[David Mitchell @DavidP4AD]

RFK, Jr. says: "I met w/PhRMA. I met w/PBMs. My job is to meet w/all the stakeholders."
We are patients-no stakeholders are more important. We've been trying to meet with him for almost 2 months. Today I reiterate our request for a meeting on behalf of patients.

[Social Security Works ❌👑 @SSWorks]

We are here in front of Pharma HQ to deliver 202K petitions demanding Pharma and their allies drop the lawsuits and allow Medicare to negotiate. Which is the law! And we will not stop fighting.

@P4AD_

[David Mitchell @DavidP4AD]

Good news from @CMSGov this AM! Trump Admin will move ahead with Medicare Rx price negotiation! Devil is in the details & how they may tweak the program. Bottom line for us: Do they deliver for patients by lowering prices by at least as much as in 1st round-- average 22%?

[David Mitchell @DavidP4AD]

Perhaps we'll learn how the Trump Admin plans to keep his promise to reduce drug prices as HHS nominee Robert F. Kennedy, Jr. appears before the Senate Finance Committee at 10am today. https://t.co/og6N2Tpd9d

[David Mitchell @DavidP4AD]

I went up to Capitol Hill yesterday to tell my patient story and emphasize the urgent need to continue implementing the IRA--especially Medicare negotiation. To do otherwise will make drug prices go up, hurting patients and millions of Americans.

[David Mitchell @DavidP4AD]

Millions of Americans are realizing serious savings on their prescriptions through the new 2022 drug law. We need the Trump administration to continue implementation of Medicare negotiation to help millions more. https://t.co/alC1G4jmil

[David Mitchell @DavidP4AD]

Love this shot! This is our work--getting patients and their stories before policymakers. And there ain't no higher policymaker than a President. Thanks to Judy for all she does for patients.

[David Mitchell @DavidP4AD]

CMS announces 15 more drugs now up for negotiation to lower prices & help make possible lower out-of-pocket expenses for folks on Medicare. The list includes one I take-Pomalyst. Sure hope the Trump Admin uses its bargaining skills to get us a great deal.https://t.co/jczdJrgmxn

[David Mitchell @DavidP4AD]

Independent polling consistently shows overwhelming bipartisan support for expanded Medicare negotiation to lower Rx drug prices.